X4 Pharmaceuticals, Inc.XFORNASDAQ
Loading
ROE: Strong ReturnsExpanding
Percentile Rank80
Studio
Year-over-Year Change

Return on equity

Latest
-42.51%
↑ 58% vs avg
Percentile
P80
Within normal range
Streak
2 yr
Consecutive growthExpanding
Average
-101.94%
Historical baseline
PeriodValueYoY Change
2025-42.51%+74.9%
2024-169.08%+14.6%
2023-197.98%-56.2%
2022-126.76%+7.9%
2021-137.70%-61.3%
2020-85.35%-94.8%
2019-43.80%+78.0%
2018-199.17%-245.2%
2017-57.71%-242.1%
201640.62%-